-
11:44:21 PM

ABT Stock News

05/31/23 9:00 AM
NYSE : ABT
Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign
Abbott, Real Madrid and the Real Madrid Foundation launch' Beat Malnutrition' campaign as part of a sustained collaboration urging communities to work together to reduce malnutrition Campaign will supply malnutrition screening tools to local communities and provide funding for malnutrition programs at Real Madrid Foundation Social Sports Schools...
RHEA-AI
neutral
05/24/23 9:00 AM
NYSE : ABT
European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations
MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients CardioMEMS is a paperclip-sized sensor that can remotely flag to a patient's clinical team the early warning signs of worsening heart failure. GDMT refers to the European and U.S. guidelines for heart failure management...
RHEA-AI
neutral
05/20/23 9:18 AM
NYSE : ABT
clinical trial
Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints
Abbott's AVEIR™ DR i2i™ IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemaker The study successfully met all three of its primary safety and performance endpoints Abbott's investigational AVEIR DR leadless pacemakers have been submitted for evaluation by the U.S. FDA.
RHEA-AI
neutral
05/19/23 9:00 AM
NYSE : ABT
fda approval
Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm
TactiFlex™ Ablation Catheter, Sensor Enabled™, is the world's first ablation catheter designed with a unique flexible electrode tip and contact force sensing to treat patients with atrial fibrillation When used with Abbott's EnSite™ X EP System, physicians have better visualization allowing for more accuracy and precision with the TactiFlex catheter,...
RHEA-AI
neutral
05/18/23 9:00 AM
NYSE : ABT
clinical trial
Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term
Abbott's Assert-IQ offers the world's longest battery life† for an insertable cardiac monitor The latest addition to Abbott's portfolio of connected health devices, the Assert-IQ ICM offers long-term monitoring and remote programming to improve connectivity to patients The device provides continuous monitoring for abnormal heart rhythms while...
RHEA-AI
neutral
05/16/23 9:00 AM
NYSE : ABT
fda approval
Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options
Abbott announced today that the U.S. Food and Drug Administration has approved its spinal cord stimulation devices for the treatment of chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back pain. "To date, we have struggled with how to treat people who weren't...
RHEA-AI
neutral